✦ LIBER ✦

Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study

✍ Scribed by Vibeke Strand, David Fiorentino, ChiaChi Hu…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Apremilast, an oral phosphodiesterase 4

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Apremilast improves pruritus in subjects

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Apremilast, an oral phosphodiesterase 4

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Long-term safety and tolerability of apr

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Improved quality of life with apremilast

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Patient-reported outcomes in moderate-to

✍ S. Tyring; J. Bagel; C. Lynde; P. Klekotka; E.H.Z. Thompson; S.R. Gandra; Y. Shi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB